Effects of Gabapentin Versus Placebo on Buprenorphine Detoxification of Opioid-dependent Individuals
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
This study involves inducting treatment seeking opioid dependent participants onto
buprenorphine. Once the participant reaches a stable dose they will receive either placebo or
gabapentin to determine if gabapentin helps ease withdrawal symptoms while the participant
undergoes a 10-day buprenorphine detoxification.
Phase:
Phase 2
Details
Lead Sponsor:
University of Arkansas
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Analgesics, Opioid Buprenorphine Buprenorphine, Naloxone Drug Combination Gabapentin gamma-Aminobutyric Acid